| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/28/2002 | EP1017734B1 Crosslinkable polyurea polymers |
| 08/28/2002 | CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1089549C Process for preparing N-acetonylbenzamide |
| 08/27/2002 | US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/27/2002 | US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity |
| 08/27/2002 | US6440929 Pulmonary delivery of active agents |
| 08/27/2002 | CA2019829C Fatty-acid-based plastics |
| 08/22/2002 | WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064130A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | WO2002064080A2 Matrix metalloproteinase inhibitors |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | US20020115701 Have antipyretic action, analgesic action, antiinflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2; ketomethylene intermediates |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | CA2437643A1 Matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232279A2 Method for producing optically active amines |
| 08/20/2002 | US6437150 Compounds having protected hydroxy groups |
| 08/20/2002 | US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |
| 08/20/2002 | US6437016 Radiation-curable compound derived from a hydroxyalkylamide |
| 08/20/2002 | US6436998 Administering amides having improved kinetics and reduced side effects; drug abuse, drug dependence |
| 08/20/2002 | US6436990 Antiinflammatory, rheumatic and antiarthritic agents, having improved transformation; side effect reduction |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | US20020110516 Synthesis of hydrogen peroxide |
| 08/14/2002 | EP1073688A4 The construction of copolymer libraries |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | CN1364153A Substituted phenoxyacetic acids |
| 08/14/2002 | CN1088992C Topically administrable compositions containing 2-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | CA2167524C Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | US20020107418 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide |
| 08/08/2002 | US20020107390 Thyromimetic organic compounds |
| 08/08/2002 | US20020107271 Heterocyclic aromatic oxazole compounds and use thereof |
| 08/08/2002 | US20020107270 Selective inhibitory action on cyclooxygenase- 2 and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders. |
| 08/08/2002 | CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells |
| 08/07/2002 | CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6428824 Treating sexual disorders with benzyl isothiocyanate, lepidium sterol component, lepidium fatty acid and a macamide component; cellulose-free |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/01/2002 | WO2002059081A2 Urea derivatives as inhibitors of ccr-3 receptor |
| 08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
| 08/01/2002 | WO2002058621A2 Substantive hydrophobic cationic uv-absorbing compounds |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | US20020103379 Making 2,2-difluoro-2-(2-pyridyl)-ethan-1-ol, by coupling 2-bromopyridine with ethyl 2-bromo-2,2-difluoroacetate, using metallic copper and solvent; chemical intermediates |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | US20020103183 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example |
| 08/01/2002 | US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/31/2002 | EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1225883A1 Anti-ischemic compounds |
| 07/31/2002 | CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha |
| 07/31/2002 | CN1088454C Synthetic method of electroactive large monomer |
| 07/30/2002 | CA2291067C Method for the preparation of citalopram |
| 07/25/2002 | WO2002057236A1 Phenyl derivatives |
| 07/25/2002 | WO2001092273A3 Benzenedicarboxylic acid derivatives |
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |
| 07/25/2002 | WO2001000665A9 Inhibitors of memapsin 2 and use thereof |
| 07/25/2002 | US20020099096 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099036 Selective androgen receptor modulators and methods of use thereof |
| 07/25/2002 | US20020098148 Radiolabelled substituted carbonylaminobenzene derivatives which bind androgen recepotr |
| 07/25/2002 | DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP0946495B1 Phenyl acetamides as spla2 inhibitors |
| 07/24/2002 | EP0760809B1 Application of omega-hydrofluoroalkyl ethers |
| 07/24/2002 | CN1088058C Modified polyunsaturated fatty acids |
| 07/23/2002 | US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/23/2002 | US6423855 Prevention lysis; oxidation resistance |
| 07/23/2002 | US6423733 Fungicidal mixtures |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002055480A2 6-substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine |
| 07/18/2002 | WO2002055454A2 Process and product |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002055011A2 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 07/18/2002 | WO2002016310A9 Selective androgen receptor modulators and methods of use thereof |
| 07/18/2002 | US20020094938 Unsaturated phenolic compound forms an amide bond with amine of fragrance; 2-(2,4-dimethylcyclohex-3-en-1-yl),3-(2-(2,4 -dihydroxyphenyl)ethenylcarbonyl)oxazolidine for example; laundry detergents, shampoos and hair conditioners |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2434409A1 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 07/18/2002 | CA2434200A1 6-substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine |
| 07/17/2002 | EP1222152A1 A method for preparing and screening one or more compounds |
| 07/17/2002 | EP1039902A4 Inhibitors of gap junction communication |
| 07/17/2002 | EP0863753B1 Use of perfluoroalkyl derivatives of amino acids as metallo-beta-lactamase inhibitors |
| 07/17/2002 | CN1359371A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 07/16/2002 | USRE37795 Biopolymers |